🇺🇸 FDA
Patent

US 12251372

Antileishmanial compounds, compositions and use thereof

granted A61KA61K31/4162A61K31/4178

Quick answer

US patent 12251372 (Antileishmanial compounds, compositions and use thereof) held by The Regents of the University of California expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/4162, A61K31/4178, A61K31/427, A61K31/437